Published in J Hepatol on March 01, 1992
Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Dig Dis Sci (1997) 1.44
Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol (1998) 1.27
Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol (2005) 1.02
Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection. J Clin Pathol (1994) 0.81
TRAF1 is a key mediator for hepatic ischemia/reperfusion injury. Cell Death Dis (2014) 0.78
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
A classification of chronic hepatitis. Lancet (1968) 6.07
Physiological consequences of loss of plasminogen activator gene function in mice. Nature (1994) 4.40
Molecular cloning of overlapping segments of the nopaline Ti-plasmid pTiC58 as a means to restriction endonuclease mapping. Plasmid (1980) 3.16
Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients. Gastroenterology (1976) 2.17
Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J Clin Invest (1993) 2.08
Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am J Pathol (2000) 1.93
High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene (2007) 1.83
'Undifferentiated progenitor cells' in focal nodular hyperplasia of the liver. Histopathology (1996) 1.83
Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour? Liver (1998) 1.67
Chronic radiodermatitis following percutaneous coronary interventions: a report of two cases. J Eur Acad Dermatol Venereol (2003) 1.64
Incomplete septal cirrhosis: histopathological aspects. Histopathology (1988) 1.63
The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study. Hepatology (1988) 1.59
Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J Hepatol (1998) 1.57
Plasmacytoid monocytes (so-called plasmacytoid T cells) in granulomatous lymphadenitis. Hum Pathol (1989) 1.51
Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood (2001) 1.47
Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology (2001) 1.46
Plasmacytoid T cells. Immunohistochemical evidence for their monocyte/macrophage origin. Am J Pathol (1988) 1.46
Immunofluorescent detection of hepatitis B antigen in paraffin-embedded liver tissue. J Immunol Methods (1975) 1.44
Distribution patterns of hepatitis B surface antigen (HBsAg) in the liver of hepatitis patients. J Clin Pathol (1976) 1.41
Vascular wound healing and neointima formation induced by perivascular electric injury in mice. Am J Pathol (1997) 1.40
Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology (1990) 1.40
Histochemistry of gamma-glutamyl transpeptidase in rat liver during aflatoxin B1-induced carcinogenesis. J Natl Cancer Inst (1975) 1.33
Administration of human fibroblast interferon in chronic hepatitis-B infection. Lancet (1976) 1.31
Collagenous colitis: an abnormal collagen table? Two new cases and review of the literature. Am J Gastroenterol (1982) 1.30
Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol (2001) 1.29
Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma. J Invest Dermatol (2001) 1.28
Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol (1990) 1.28
In situ distribution of major histocompatibility complex products and viral antigens in chronic hepatitis B virus infection: evidence that HBc-containing hepatocytes may express HLA-DR antigens. Hepatology (1986) 1.24
A case of human orf in an immunocompromised patient treated successfully with cidofovir cream. J Med Virol (2001) 1.23
Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study. Hum Pathol (1988) 1.23
A cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express 'bile duct-type' cytokeratins. Histopathology (1989) 1.23
Intrahepatic bile ducts under the lens. J Hepatol (1985) 1.22
Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Virchows Arch A Pathol Anat Histopathol (1987) 1.21
Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases. Hepatology (1988) 1.20
Expression of the endothelin-B receptor in pigment cell lesions of the skin. Evidence for its role as tumor progression marker in malignant melanoma. Virchows Arch (2001) 1.16
Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clin Neuropathol (1990) 1.16
POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands. J Pathol (2008) 1.15
Hepatitis-B surface antigen in tumour tissue and non-tumorous liver in black patients with hepatocellular carcinoma. Br J Cancer (1980) 1.14
Synaptophysin: A novel marker for human and rat hepatic stellate cells. Am J Pathol (1999) 1.11
Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology (1992) 1.09
Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease. Gastroenterology (1992) 1.08
The transitional zone between limbus and peripheral cornea. An immunohistochemical study. Invest Ophthalmol Vis Sci (1993) 1.07
Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis. J Hepatol (1991) 1.07
Heparan sulfate proteoglycan expression in normal human liver. Hepatology (1995) 1.06
Hepatitis B surface antigen (HBsAg) in the liver of patients with hepatitis; a comparison with serological detection. J Clin Pathol (1976) 1.05
Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol (1993) 1.05
Immature sinus histiocytosis. Light- and electron-microscopic features, immunologic phenotype, and relationship with marginal zone lymphocytes. Am J Pathol (1985) 1.05
Distribution of the VLA family of integrins in normal and pathological human liver tissue. Gastroenterology (1991) 1.04
Expression of MHC products by normal and abnormal bile duct epithelium. J Hepatol (1986) 1.04
Granulomatous gastritis: a morphological and diagnostic approach. Histopathology (1993) 1.03
Heparan sulphate proteoglycan expression in human primary liver tumours. J Pathol (1998) 1.02
Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. An immunohistochemical study. J Hepatol (1990) 1.01
Cells with neuroendocrine features in regenerating human liver. APMIS Suppl (1991) 1.01
Practical suggestions for successful immunoenzyme double-staining experiments. Histochem J (1993) 1.00
Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases. J Hepatol (1986) 1.00
Progressive intrahepatic cholestasis (Byler's disease): case report. Gut (1975) 1.00
alpha-1-Antitrypsin immunoreactivity in islet cells of adult human pancreas. Cell Tissue Res (1977) 1.00
Hepatic endoplasmic reticulum storage diseases. Liver (1992) 1.00
Parathyroid hormone-related peptide expression in primary and metastatic liver tumours. Histopathology (1993) 0.99
Morphologic changes of the junctional complex of the hepatocytes in rat liver after bile duct ligation. Br J Exp Pathol (1978) 0.98
Langerhans cells in various benign and malignant pigment-cell lesions of the skin. Arch Dermatol Res (1984) 0.98
Hepatic expression of intercellular adhesion molecule-1 (ICAM-1) in viral hepatitis B. Hepatology (1990) 0.97
Distribution of very late activation integrins in the human cornea. An immunohistochemical study using monoclonal antibodies. Invest Ophthalmol Vis Sci (1991) 0.97
Papuloerythroderma: report of a European case. Dermatology (1993) 0.97
HLA expression in human hepatocellular carcinoma. Br J Cancer (1988) 0.95
Cellular composition of hypersensitivity-type granulomas: immunohistochemical analysis of tuberculous and sarcoidal lymphadenitis. Hum Pathol (1984) 0.95
Differential expression of the calcium-binding proteins MRP8 and MRP14 in granulomatous conditions: an immunohistochemical study. Clin Exp Immunol (1990) 0.95
Thyroid hormones and the hepatic handling of bilirubin. I. Effects of hypothyroidism and hyperthyroidism on the hepatic transport of bilirubin mono- and diconjugates in the Wistar rat. Hepatology (1989) 0.95
t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases. Mod Pathol (1995) 0.95
The marginal zone in the human reactive lymph node. Am J Clin Pathol (1986) 0.94
Desmin expressing nonhematopoietic liver cells during rat liver development: an immunohistochemical and morphometric study. Differentiation (1995) 0.94
Histochemical study of rat liver in alpha-naphthyl isothiocyanate (ANIT) induced cholestasis. Am J Pathol (1968) 0.94
Evaluation of a modified fluorescent technique for the detection of Australia antigen in liver tissue. J Immunol Methods (1974) 0.94
A new epithelial cell type in the human cornea. Invest Ophthalmol Vis Sci (1993) 0.93
Improved immunohistochemical visualization of helper/inducer T-cells by the simultaneous application of two noncrossblocking monoclonal antibodies. Stain Technol (1985) 0.93
Current problems in diagnosis of biliary disease and cholestasis. Semin Liver Dis (1986) 0.92